MedCity INVEST Precision Medicine spotlight: Pitch Perfect Life Science track (video)
A video from the conference spotlights startup pitches and Q&A with judges in the Life Science track of the Pitch Perfect contest.
A video from the conference spotlights startup pitches and Q&A with judges in the Life Science track of the Pitch Perfect contest.
Judges picked TrialSpark as the winner on the life sciences track of the pitch competition at MedCity's virtual precision medicine conference. While the company is focused on improving clinical trials for others, it hopes eventually to bring drugs of its own to market.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The final day of the conference, Friday, December 11, includes a panel on precision medicine investment trends, a look at clinical trial design innovation and the life sciences track of our Pitch Perfect startup contest. Register now!
In a panel discussion geared to leaders of early stage companies, a mix of angel and venture investors offered some insights to give entrepreneurs some food for thought in different stages of their dealings with investors. The conversation at the IMPACT 2014 conference in Philadelphia this week included Ellen Weber of Robin Hood Ventures who […]
Ellen Weber, who heads up angel investment group Robin Hood Ventures, has been named as the new head of Temple University’s Innovation and Entrepreneurship Institute as part of its business school, according to a statement from the university. She will also head up angel investor group Mid Atlantic Diamond Ventures, which is run out of […]
With President Barack Obama signing the Jumpstart Our Business Startups Bill into law today, the crowdfunding provision could mark a new era for startups and make it easier to raise money with more investment from new investors who fuel early and later-stage healthcare companies. But some investors believe that with less-rigorous regulatory checks and balances […]